Keep FIRDAPSE and all medicines out of the reach of children
Please choose one of the following injection day schedules and try to keep it consistent each week

Cost-benefit analysis Research cagrilintide monotherapy: Cost: $800-1,600/month Weight loss: 10-12% over 68 weeks Total investment: $12,000-24,000 (18 months) Per pound lost (220 lb person, 24 lbs): $500-1,000/lb CagriSema combination: Cagrilintide: $800-1,600/month Semaglutide: $150-300/month Total: $950-1,900/month Weight loss: 15-25% (33-55 lbs for 220 lb person) Total investment: $14,000-28,000 (18 months) Per pound lost: $250-850/lb Better value than monotherapy Comparison to bariatric surgery: Surgery: $15,000-25,000 upfront Weight loss: 25-35% One-time cost Permanent anatomical change CagriSema approaching surgery results without surgery Making it more affordable: Use maintenance doses after titration (lower cost) Consider semaglutide alone initially (cheaper, effective) Add cagrilintide if plateau Budget long-term (12-18 months minimum) Use our peptide cost calculator at SeekPeptides to budget your weight loss protocol accurately

The short answer most clinicians give surprises people: most of them take both
In gastrointestinal research, BPC-157 is commonly studied through: gastric mucosal integrity intestinal barrier markers ulceration model scoring inflammatory mediator panels blood vessel response histology analysis NO pathway markers oxidative stress markers A 2020 study investigated stable gastric pentadecapeptide BPC-157 in clopidogrel-induced gastric injury models, looking at gastric protection and injury marker changes
Aging Dis 16:2870